WAKIX (pitolisant HCl)
NARCOLEPSY THERAPY - H3-RECEPTOR ANTAGONIST/INVERSE AGONIST · NARCOLEPSY SYNDROME ·+1
HARMONY BIOSCIE
Drug class
Narcolepsy Therapy - H3-Receptor Antagonist/Inverse Agonist
Narcolepsy therapy involving histamine H3-receptor antagonists/inverse agonists is a pharmacotherapeutic class primarily represented by pitolisant. Read more about Narcolepsy Therapy - H3-Receptor Antagonist/Inverse Agonist
1 drugs in this class 1 manufacturers
Drugs in Narcolepsy Therapy - H3-Receptor Antagonist/Inverse Agonist
Filter & compare in the drug finder →
Opens the drug finder with Narcolepsy Therapy - H3-Receptor Antagonist/Inverse Agonist preselected. Add indication or manufacturer filters there.
Narcolepsy therapy involving histamine H3-receptor antagonists/inverse agonists is a pharmacotherapeutic class primarily represented by pitolisant.
These agents work by selectively binding to presynaptic histamine H3 autoreceptors in the central nervous system, blocking inhibitory feedback and reversing constitutive receptor activity to stimulate the synthesis and synaptic release of wake-promoting histamine.
This enhanced histaminergic transmission stabilizes sleep-wake signaling networks.
Clinically, medications in this class are indicated to treat excessive daytime sleepiness and cataplexy in pediatric and adult patients with narcolepsy.
-
pharmacytimes.com
Narcolepsy therapy involving histamine H3-receptor antagonists/inverse agonists is a pharmacotherapeutic class primarily represented by pitolisant These agents work by selectively binding to presynaptic histamine H3 autoreceptors in the central nervous system, blocking inhibitory feedback and reversing constitutive receptor activity to stimulate the synthesis and synaptic release of wake-promoting histamine Clinically, medications in this class are indicated to treat excessive daytime sleepiness...
-
neurologylive.com
Narcolepsy therapy involving histamine H3-receptor antagonists/inverse agonists is a pharmacotherapeutic class primarily represented by pitolisant Clinically, medications in this class are indicated to treat excessive daytime sleepiness and cataplexy in pediatric and adult patients with narcolepsy
-
rxlist.com
These agents work by selectively binding to presynaptic histamine H3 autoreceptors in the central nervous system, blocking inhibitory feedback and reversing constitutive receptor activity to stimulate the synthesis and synaptic release of wake-promoting histamine
-
wakixhcp.com
These agents work by selectively binding to presynaptic histamine H3 autoreceptors in the central nervous system, blocking inhibitory feedback and reversing constitutive receptor activity to stimulate the synthesis and synaptic release of wake-promoting histamine This enhanced histaminergic transmission stabilizes sleep-wake signaling networks Clinically, medications in this class are indicated to treat excessive daytime sleepiness and cataplexy in pediatric and adult patients with narcolepsy
-
tandfonline.com
This enhanced histaminergic transmission stabilizes sleep-wake signaling networks
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.